Test ID: BTK
Bruton Tyrosine Kinase (Btk), Protein Expression, Flow Cytometry, Blood
Method Description
Describes how the test is performed and provides a method-specific reference
The Bruton tyrosine kinase (Btk) protein expression screening assay is carried out with a whole blood sample. The cells in the blood are stained with antihuman CD20 (B cells) and CD14 (monocytes) antibodies, which is followed by red blood cell lysis (using a premade Lysis buffer), cell fixation, and permeabilization to prepare the cell membrane for the antihuman Btk antibody. After the permeabilization step, the cells are stained for intracellular Btk using antihuman Btk-fluorescent preconjugated antibody (BD Biosciences). After the staining and wash process, the cells are resuspended in 500 mcL of 1% paraformaldehyde in the final step of the assay and the sample is analyzed by multiparametric flow cytometry.(Unpublished Mayo method; Futatani T, Miyawaki T, Tsukada S, et al: Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998;91[2]:595-602)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday
Do not send specimen after Thursday. Specimen must be received by 10 a.m. on Friday.


